CREM and melanoma: Concordant ChIP-SEQ results coupled with our RNA-seq analysis provides evidence of ICER regulation, and antagonism of CREM/CREB, however, absent melanoma specific ChIP-seq data targeting CREM, it is unclear how cell type specific chromatin accessibility may impact ICER/CREM binding.